Cargando…
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920486/ https://www.ncbi.nlm.nih.gov/pubmed/23385377 http://dx.doi.org/10.1038/leu.2013.37 |
_version_ | 1782303177788358656 |
---|---|
author | Herman, SEM Barr, PM McAuley, EM Liu, D Wiestner, A Friedberg, JW |
author_facet | Herman, SEM Barr, PM McAuley, EM Liu, D Wiestner, A Friedberg, JW |
author_sort | Herman, SEM |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3920486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-39204862014-02-11 Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia Herman, SEM Barr, PM McAuley, EM Liu, D Wiestner, A Friedberg, JW Leukemia Article 2013-02-06 2013-08 /pmc/articles/PMC3920486/ /pubmed/23385377 http://dx.doi.org/10.1038/leu.2013.37 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Herman, SEM Barr, PM McAuley, EM Liu, D Wiestner, A Friedberg, JW Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
title | Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
title_full | Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
title_fullStr | Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
title_full_unstemmed | Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
title_short | Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
title_sort | fostamatinib inhibits b-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920486/ https://www.ncbi.nlm.nih.gov/pubmed/23385377 http://dx.doi.org/10.1038/leu.2013.37 |
work_keys_str_mv | AT hermansem fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia AT barrpm fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia AT mcauleyem fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia AT liud fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia AT wiestnera fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia AT friedbergjw fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia |